SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000927016-03-001558
Filing Date
2003-03-31
Accepted
2003-03-31 16:47:41
Documents
8
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.txt 10-K 246849
3 RESEARCH COLLABORATION & LICENSE AGREEMENT dex1062.txt EX-10.62 172438
4 STOCK PURCHASE AGREEMENT dex1063.txt EX-10.63 87444
5 LETTER TO CLAUDIO QUARTA FROM CEO dex1064.txt EX-10.64 2852
6 CONSENT OF ERNST & YOUNG INDEPENDENT PUBLIC ACCOUNTANTS dex231.txt EX-23.1 740
7 RISK FACTORS dex991.txt EX-99.1 39503
8 LETTER FROM CEO dex992.txt EX-99.2 1331
9 LETTER FROM CFO dex993.txt EX-99.3 1336
  Complete submission text file 0000927016-03-001558.txt   554951
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
GENOME THERAPEUTICS CORP (Filer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 000-10824 | Film No.: 03631520
SIC: 2835 In Vitro & In Vivo Diagnostic Substances